SLI
1.972,23
PKT
-6,50
PKT
-0,33
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.10.15 | Roche overweight | JP Morgan Chase & Co. | |
| 23.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.10.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 23.10.15 | Swiss Re buy | Citigroup Corp. | |
| 23.10.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 22.10.15 | UBS Verkaufen | Bankhaus Lampe KG | |
| 22.10.15 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 22.10.15 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.15 | Roche buy | Kepler Cheuvreux | |
| 22.10.15 | UBS Neutral | UBS AG | |
| 22.10.15 | UBS buy | Nomura | |
| 22.10.15 | Novartis Outperform | BNP PARIBAS | |
| 22.10.15 | UBS Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.15 | ABB (Asea Brown Boveri) Sell | Société Générale Group S.A. (SG) | |
| 22.10.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 22.10.15 | ABB (Asea Brown Boveri) buy | HSBC | |
| 21.10.15 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
| 21.10.15 | UBS Sell | Société Générale Group S.A. (SG) | |
| 21.10.15 | Holcim overweight | Morgan Stanley | |
| 21.10.15 | UBS Halten | Independent Research GmbH | |
| 21.10.15 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 21.10.15 | UBS Halten | Bankhaus Lampe KG | |
| 21.10.15 | UBS buy | Nomura | |
| 21.10.15 | UBS kaufen | S&P Capital IQ | |
| 21.10.15 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 21.10.15 | UBS overweight | Barclays Capital | |
| 21.10.15 | UBS Underperform | Merrill Lynch & Co., Inc. | |
| 21.10.15 | Roche Outperform | Bernstein Research | |
| 21.10.15 | Novartis Outperform | Bernstein Research | |
| 21.10.15 | UBS Reduce | Kepler Cheuvreux | |
| 21.10.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 20.10.15 | Roche buy | UBS AG | |
| 20.10.15 | Givaudan Underweight | Barclays Capital | |
| 20.10.15 | Swiss Re Equal weight | Barclays Capital | |
| 20.10.15 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 19.10.15 | Nestlé Underperform | BNP PARIBAS | |
| 19.10.15 | Nestlé Halten | Independent Research GmbH |